
The active compounds, hypericin and hyperforin, are thought to inhibit the reuptake of key neurotransmitters, increasing their availability in the brain. It has significant potential for drug interactions and should be used with medical guidance.
- Focuses on
- Most relevant for
- Adults experiencing mild to moderate low mood who are seeking a researched herbal alternative with potentially fewer side effects than synthetic antidepressants.
Potential benefits
- Mild-to-moderate low mood support.Extensive systematic reviews indicate that specific standardized extracts can be more effective than placebo for managing symptoms of mild to moderate major depression.
- Comparable to standard options.Multiple clinical trials have found that St. John's Wort may perform similarly to certain standard antidepressants, such as SSRIs, in reducing depressive symptom scores.
- Improved tolerability.Clinical data often shows that participants using St. John's Wort report fewer side effects and are less likely to withdraw from studies compared to those taking synthetic antidepressants.
Limitations
- Inconsistent clinical findings.Several high-quality, placebo-controlled trials have shown no significant benefit, suggesting that outcomes can vary greatly depending on the population and study design.
- Variable efficacy in minor mood shifts.Research specifically targeting minor depression has failed to show a benefit over placebo, indicating it may not be effective for very mild or sub-clinical mood concerns.
- Extract-specific results.Most supportive evidence is based on specific standardized extracts like WS 5570 or LI 160; results may not apply to all available over-the-counter preparations.
Things to consider
St. John's Wort has a high potential for serious drug interactions, which can reduce the effectiveness of medications like birth control and blood thinners; medical supervision is essential.
Study evidence
97 studiesSt. John's Wort has evidence for reducing symptoms of mild to moderate major depression, although results vary across trials and extracts. This does not establish a general mood boost in people without depression, and its potential to interfere with other medicines is a meaningful limitation.
